Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes. 1994

M Zeggari, and J P Esteve, and I Rauly, and C Cambillau, and H Mazarguil, and M Dufresne, and L Pradayrol, and J A Chayvialle, and N Vaysse, and C Susini
INSERM U151, CHU Rangueil, Toulouse, France.

We have previously shown that somatostatin promotes the stimulation of a membrane tyrosine phosphatase activity in pancreatic cells. To gain insight into the mechanism of somatostatin action, we purified somatostatin-receptor complexes from somatostatin 28-prelabelled rat pancreatic plasma membranes by immunoaffinity chromatography using immobilized antibodies raised against the N-terminal part of somatostatin 28, somatostatin 28 (1-14), which is not involved in receptor-binding-site recognition. After SDS gel electrophoresis a band with a molecular mass of 87 kDa was identified in the affinity-purified material as the somatostatin receptor. The 87 kDa protein was not observed when the membrane receptors were solubilized in a free unoccupied or somatostatin 14-occupied form, or when nonimmune serum replaced the anti-[somatostatin 28 (1-14)] anti-serum. Somatostatin 14 inhibited the appearance of the 87 kDa protein in the same range of concentrations that inhibit radioligand binding on pancreatic membranes. After somatostatin 28 treatment of membranes, purified somatostatin receptor preparations exhibited an elevated tyrosine phosphatase activity that dephosphorylated phosphorylated epidermal growth factor receptor and poly(Glu,Tyr). This activity was related to the presence of somatostatin receptors in purified material. It was increased by dithiothreitol and inhibited by orthovanadate. In purified material containing somatostatin receptors, anti-[Src homology 2 domains (SH2)]-containing tyrosine phosphatase SHPTP1 polyclonal antibodies identified a protein of 66 kDa which was not detected in the absence of somatostatin receptor. Furthermore, the anti-SHPTP1 antibodies immunoprecipitated specific somatostatin receptors from somatostatin-prelabelled pancreatic membranes and from untreated membranes. These results indicate that a 66 kDa tyrosine phosphatase related to SHPTP1 co-purifies with the pancreatic somatostatin receptors, and suggest that this protein is associated with somatostatin receptors at the membrane level.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D011498 Protein Precursors Precursors, Protein
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography

Related Publications

M Zeggari, and J P Esteve, and I Rauly, and C Cambillau, and H Mazarguil, and M Dufresne, and L Pradayrol, and J A Chayvialle, and N Vaysse, and C Susini
August 1987, Nihon Naibunpi Gakkai zasshi,
M Zeggari, and J P Esteve, and I Rauly, and C Cambillau, and H Mazarguil, and M Dufresne, and L Pradayrol, and J A Chayvialle, and N Vaysse, and C Susini
January 1988, Pancreas,
M Zeggari, and J P Esteve, and I Rauly, and C Cambillau, and H Mazarguil, and M Dufresne, and L Pradayrol, and J A Chayvialle, and N Vaysse, and C Susini
January 1997, Life sciences,
M Zeggari, and J P Esteve, and I Rauly, and C Cambillau, and H Mazarguil, and M Dufresne, and L Pradayrol, and J A Chayvialle, and N Vaysse, and C Susini
September 1987, The American journal of physiology,
M Zeggari, and J P Esteve, and I Rauly, and C Cambillau, and H Mazarguil, and M Dufresne, and L Pradayrol, and J A Chayvialle, and N Vaysse, and C Susini
July 1988, The American journal of physiology,
M Zeggari, and J P Esteve, and I Rauly, and C Cambillau, and H Mazarguil, and M Dufresne, and L Pradayrol, and J A Chayvialle, and N Vaysse, and C Susini
September 1988, The Biochemical journal,
M Zeggari, and J P Esteve, and I Rauly, and C Cambillau, and H Mazarguil, and M Dufresne, and L Pradayrol, and J A Chayvialle, and N Vaysse, and C Susini
July 1986, Nihon Naibunpi Gakkai zasshi,
M Zeggari, and J P Esteve, and I Rauly, and C Cambillau, and H Mazarguil, and M Dufresne, and L Pradayrol, and J A Chayvialle, and N Vaysse, and C Susini
January 1986, The Journal of biological chemistry,
M Zeggari, and J P Esteve, and I Rauly, and C Cambillau, and H Mazarguil, and M Dufresne, and L Pradayrol, and J A Chayvialle, and N Vaysse, and C Susini
July 1986, Nihon Naibunpi Gakkai zasshi,
M Zeggari, and J P Esteve, and I Rauly, and C Cambillau, and H Mazarguil, and M Dufresne, and L Pradayrol, and J A Chayvialle, and N Vaysse, and C Susini
February 1995, The American journal of physiology,
Copied contents to your clipboard!